The sublineage — BA.2.12.1 — accounted for 28.7 percent of new COVID-19 cases in the week ending April 23, according to the CDC’s latest variant proportion estimates. This figure is up from 19.4 percent in the week ending April 16 and 13.7 percent in the week ending April 9.
While BA.2 is still the nation’s dominant strain, its prevalence has fallen from 74.9 percent on April 9 to 68.1 percent as of April 23.
BA.2.12.1 is estimated to have a 27 percent growth advantage over BA.2, which is already more transmissible than the original omicron strain. The sublineage and a closely related strain called BA.2.12 are widely circulating in New York and likely contributing to an uptick in cases, health officials said April 13.
Nationwide, COVID-19 cases have increased 53 percent over the past 14 days as of April 25, according to HHS data tracked by The New York Times.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
